Tracking Medicare news, policy, and coverage changes.
Egg freezing has gained popularity as a fertility preservation tool, but experts say high costs, uncertain outcomes and timing challenges continue to deter many women from pursuing it. The post The 3 Biggest Roadblocks to Egg Freezing — and How Providers Are Working to Remove Them appeared first on MedCity News .
Read full article →Healthcare advocates warn that a new CMS rule on Medicaid work requirement exemptions could increase red tape and cause eligible people to lose coverage. The post Will CMS’ Last-Minute Medicaid Work Requirement Changes Cause More Harm? appeared first on MedCity News .
Read full article →You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference.
Read full article →(MedPage Today) -- NEW ORLEANS -- Participants with obesity achieved weight loss on par with bariatric surgery and had improvements in two obesity-related conditions while taking a once-weekly investigational triple hormone receptor agonist...
Read full article →(MedPage Today) -- NEW ORLEANS -- Monotherapy with once-weekly retatrutide, an investigational triple hormone receptor agonist, improved glycemic control and body weight in adults with type 2 diabetes, the phase III TRANSCEND-T2D-1 trial showed...
Read full article →(MedPage Today) -- NEW ORLEANS -- Once-daily orforglipron (Foundayo) improved outcomes in adults with type 2 diabetes and inadequate glycemic control, the international ACHIEVE-5 trial showed. In patients already taking background insulin glargine...
Read full article →(MedPage Today) -- "I realize we're close to beer time here -- promise to at least give you something very scintillating." -- Paul Richardson, MD, of the Dana-Farber Cancer Institute in Boston, before presenting trial results for a novel oral...
Read full article →(MedPage Today) -- LONDON -- Late-breaking abstracts presented at the European Alliance of Associations for Rheumatology's (EULAR) annual meeting, held here last week, addressed a wide range of clinical concerns and suggested that patients and...
Read full article →(MedPage Today) -- NEW ORLEANS -- Petrelintide, an investigational long-acting amylin analog, induced significant weight loss with minimal side effects in the global phase II ZUPREME-1 study. By week 28, all five investigational doses of petrelintide...
Read full article →Sanford Health moves to add North Memorial Health, Sutter Health and Allina Health sign a definitive agreement and more merger and acquisition news from May.
Read full article →Trump administration wants ill recipients to prove they can’t work every six months. Doctors, advocates and state officials wonder how.
Read full article →Boehringer Ingelheim’s obesity drug showed promise in cutting liver fat, but it was less impressive at overall weight loss, new data shows.
Read full article →